COVID-19-Associated Pulmonary Mucormycosis DOI Creative Commons
Vidya Krishna, N.K. Bansal, Jaymin B. Morjaria

et al.

Journal of Fungi, Journal Year: 2022, Volume and Issue: 8(7), P. 711 - 711

Published: July 5, 2022

COVID-19-associated mucormycosis (CAM) emerged as an epidemic in certain parts of the world amidst global COVID-19 pandemic. While rhino-orbital was well reported during pandemic, absence routine diagnostic facilities including lower airway sampling, pulmonary probably under-recognized. In this review, we have focused on epidemiology and management (CAPM). CAPM is a deadly disease mortality can be high 80% early clinical suspicion treatment. histopathological examination tissue for angio-invasion cultures remained gold standard diagnosis, there increasing interest molecular serological methods to facilitate diagnosis critically ill patients often, immune-suppressed hosts who cannot readily undergo invasive sampling. Combined medical surgical treatment offers more promise than standalone therapy. Maintaining adequate glycemic control prudent use steroids which double-edged sword are key preventative measures. We would like emphasize urgent need development validation reliable biomarkers diagnostics diagnosis.

Language: Английский

Resolving the equation between mucormycosis and COVID-19 disease DOI Open Access
Ritu Pasrija, Mohammad Naime

Molecular Biology Reports, Journal Year: 2022, Volume and Issue: 49(4), P. 3349 - 3356

Published: Jan. 22, 2022

Language: Английский

Citations

23
Epidemiology of COVID-19–Associated Mucormycosis DOI Open Access

Khadija Tayabali,

Hussein Pothiwalla,

Shivakumar Narayanan

et al.

Current Fungal Infection Reports, Journal Year: 2023, Volume and Issue: 17(2), P. 156 - 175

Published: May 3, 2023

Language: Английский

Citations

14
First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus DOI Open Access

Jyoti Diwakar,

Arghadip Samaddar, Subhas Konar

et al.

Journal de Mycologie Médicale, Journal Year: 2021, Volume and Issue: 31(4), P. 101203 - 101203

Published: Sept. 4, 2021

Language: Английский

Citations

31
Pulmonary aspergillosis and cryptococcosis as a complication of COVID-19 DOI Creative Commons
Edward C Traver, Melanie Malavé Sánchez

Medical Mycology Case Reports, Journal Year: 2022, Volume and Issue: 35, P. 22 - 25

Published: Jan. 6, 2022

Invasive fungal infections may complicate infection by SARS-CoV-2 and increase morbidity mortality. A 59-year-old man with multiple medical comorbidities was transferred to our hospital for worsening hypoxic respiratory failure due COVID-19 received high-dose corticosteroids 2 doses of cyclophosphamide. He diagnosed pulmonary aspergillosis cryptococcosis culture a bronchoalveolar lavage sample. This patient's secondary were likely treatment immunosuppressants, his comorbidities, prolonged critical illness.

Language: Английский

Citations

20
COVID-19-Associated Pulmonary Mucormycosis DOI Creative Commons
Vidya Krishna, N.K. Bansal, Jaymin B. Morjaria

et al.

Journal of Fungi, Journal Year: 2022, Volume and Issue: 8(7), P. 711 - 711

Published: July 5, 2022

COVID-19-associated mucormycosis (CAM) emerged as an epidemic in certain parts of the world amidst global COVID-19 pandemic. While rhino-orbital was well reported during pandemic, absence routine diagnostic facilities including lower airway sampling, pulmonary probably under-recognized. In this review, we have focused on epidemiology and management (CAPM). CAPM is a deadly disease mortality can be high 80% early clinical suspicion treatment. histopathological examination tissue for angio-invasion cultures remained gold standard diagnosis, there increasing interest molecular serological methods to facilitate diagnosis critically ill patients often, immune-suppressed hosts who cannot readily undergo invasive sampling. Combined medical surgical treatment offers more promise than standalone therapy. Maintaining adequate glycemic control prudent use steroids which double-edged sword are key preventative measures. We would like emphasize urgent need development validation reliable biomarkers diagnostics diagnosis.

Language: Английский

Citations

20